「and me」の検索結果
13件：6～10件目を表示
-
製品開発方針 | 研究開発活動 | 千寿製薬株式会社
X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob ...
https://www.senju.co.jp/rd/policy/ -
grapher equipped with Auto Refract Keratometer, Topographer, Wavefront, Dry eye analysis (optional) and Meibomian glands analysis, as the device is all in one with functionality and operability. This ...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240726.pdf -
elona, Spain; CEO: Jordi Martínez Rotllan; hereinafter “Brill”). Brill specializes in R&D, drug and medical device manufacturing, and sells its products primarily in Europe and the US. The Corneal...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf -
Product Development Policy | Research & Development | SENJU Pharmaceutica
roduct Planning DepartmentDirectorYasunobu Maenaka With the management philosophy of “Good Company” and a company that shapes “Beyond eyesight,” we have developed products that contribute to maintenan...
http://www.senju.co.jp/english/rd/policy/ -
Data And Statistics | About Senju | SENJU Pharmaceutical
2.4 Ordinary Profit 8.0 9.1 8.7 9.1 2.9 Total Assets 75.8 83.9 88.2 98.4 100.2 ＊A new accounting standard for revenue recognition has been applied since FY (financial year) 2021. Unit: Billion yen Sa...
https://www.senju.co.jp/english/about/sales.html